The medication error forced the resident into a week-long hospital stay for emergency intravenous steroid treatment to prevent organ rejection. A cardiology nurse from the patient's transplant team warned that such errors "can be irreversible and could have resulted in a severe outcome."
The resident, identified as Resident #40 in the May inspection report, had received an organ transplant in 2021 and required daily tacrolimus to prevent rejection. When the patient returned to the nursing home from a hospital stay on February 27, 2025, staff discontinued the medication entirely due to what administrators later called a "glitch" in the electronic health record system.
Nobody noticed the missing medication for nearly three weeks.
The patient's tacrolimus level, drawn on March 6, came back dangerously low at 1.2 ng/ml. The results arrived at the facility on March 11 but weren't reviewed by staff until March 13. Even then, nobody contacted the transplant team as required by physician orders.
The cardiology team only discovered the problem on March 19 when they finally received lab results and medication lists they had been requesting since February 27. "The Resident had gone a significant amount of time without the anti-rejection medication before she was able to speak with someone at the facility," the cardiology nurse told inspectors.
She described "extensive hurdles" and "many barriers" when trying to reach nursing staff or providers at the facility. The transplant coordinator ultimately recommended emergency hospitalization after learning the patient hadn't received tacrolimus since readmission.
Regional Nurse Consultant #1, who was acting as director of nursing during the incident, told inspectors the medication order had been entered as a one-time dose "maybe due to a glitch." She said staff were later reeducated on medication reconciliation procedures.
But that education appears to have missed its mark entirely.
When inspectors showed the March 20 education sheet to nursing staff, they had no idea what it was about. Nurse #4 thought the training covered explaining medications to residents at discharge. Unit Manager #1 believed it related to reviewing medications with family members. Neither recalled any specific education about the transplant patient's medication error.
"If the education was specific to a resident, the resident's initials would be on the Education Sheet and there were no initials," Unit Manager #1 explained. Nurse #2 said he "did not recall any education or in-servicing specifically related to Resident #40."
The facility's performance improvement plan identified the medication error but failed to address multiple other breakdowns in the case. Inspectors found no evidence that staff had obtained the required tacrolimus level on March 3 as recommended in hospital discharge instructions. The plan also ignored communication failures with the cardiology team and the missing pharmacy review required after readmission.
Most significantly, the improvement plan contained no benchmarks or targets for monitoring future performance, as required by federal regulations.
The problems extended beyond this single case. Inspectors discovered that five staff members, including two nurses, a unit manager, a social worker, and the staff development coordinator, had received no training on the facility's Quality Assurance Performance Improvement program despite facility policy requiring such education for all staff.
"I was not familiar with the facility's QAPI program," Nurse #1 told inspectors. "I was not sure what the goals of the program were or what my role in it was."
The social worker said there "was not any information related to the QAPI program during orientation or after she was hired." Unit Manager #2 attended quality meetings but "could not recall any in-servicing or education she completed in relation to the process."
Even the staff development coordinator, hired in February 2025, said she "did not recall completing any training on the facility's QAPI program" and "did not review QAPI with staff during orientation."
The facility's own policy, revised in April 2022, explicitly states that "small group education sessions on QAPI are provided to all caregivers" and that "QAPI is also part of orientation for new staff members." The policy assigns the administrator responsibility for "ongoing orientation, education and training on QAPI."
None of that happened.
The transplant patient's case reveals a cascade of system failures that federal regulators say put residents at risk. The medication error itself was compounded by delayed lab monitoring, poor communication with specialty providers, and ineffective quality improvement processes designed to prevent such incidents.
For transplant recipients, tacrolimus represents the difference between a functioning organ and rejection. The drug suppresses the immune system to prevent it from attacking the transplanted organ. Missing doses can trigger rejection episodes that may be impossible to reverse.
The cardiology nurse's warning proved prophetic. The patient required not just emergency hospitalization but intensive treatment with intravenous steroids to counteract the effects of missing anti-rejection medication for nearly three weeks.
Federal inspectors cited the facility for failing to maintain an effective quality assurance program and for not training staff on quality improvement procedures. The violations carry minimal harm ratings but affect multiple residents who depend on the facility's ability to learn from mistakes and prevent future errors.
The Regional Director of Operations told inspectors that the performance improvement plan was reviewed at the facility's monthly quality meeting. But with staff untrained on quality processes and improvement plans that ignore key system failures, the same problems that endangered the transplant patient could easily recur.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Regalcare At Taunton from 2025-05-13 including all violations, facility responses, and corrective action plans.